Product NDC: | 55513-955 |
Proprietary Name: | Vectibix |
Non Proprietary Name: | panitumumab |
Active Ingredient(s): | 200 mg/10mL & nbsp; panitumumab |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55513-955 |
Labeler Name: | Amgen Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125147 |
Marketing Category: | BLA |
Start Marketing Date: | 20061010 |
Package NDC: | 55513-955-01 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (55513-955-01) > 10 mL in 1 VIAL, SINGLE-USE |
NDC Code | 55513-955-01 |
Proprietary Name | Vectibix |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (55513-955-01) > 10 mL in 1 VIAL, SINGLE-USE |
Product NDC | 55513-955 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | panitumumab |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20061010 |
Marketing Category Name | BLA |
Labeler Name | Amgen Inc |
Substance Name | PANITUMUMAB |
Strength Number | 200 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Epidermal Growth Factor Receptor Antagonist [EPC] |